SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-116491
Filing Date
2022-11-09
Accepted
2022-11-09 16:17:31
Documents
14
Period of Report
2022-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2230075d1_8k.htm   iXBRL 8-K 24726
2 EXHIBIT 99.1 tm2230075d1_ex99-1.htm EX-99.1 112441
6 GRAPHIC tm2230075d1_ex99-1img001.jpg GRAPHIC 4309
  Complete submission text file 0001104659-22-116491.txt   328507

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA inva-20221109.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20221109_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20221109_pre.xml EX-101.PRE 22587
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2230075d1_8k_htm.xml XML 3604
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 221372875
SIC: 2834 Pharmaceutical Preparations